2023 Q2 Form 10-Q Financial Statement

#000162828023015436 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $514.5M $527.0M
YoY Change -1.56% -2.88%
Cost Of Revenue $354.6M $361.5M
YoY Change -3.04% -4.53%
Gross Profit $159.9M $165.5M
YoY Change 1.9% 0.92%
Gross Profit Margin 31.08% 31.41%
Selling, General & Admin $49.02M $51.94M
YoY Change 9.79% -14.76%
% of Gross Profit 30.65% 31.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $15.69M $14.72M
YoY Change 23.2% 23.29%
% of Gross Profit 9.81% 8.89%
Operating Expenses $123.7M $127.7M
YoY Change 4.81% -4.26%
Operating Profit $36.22M $37.80M
YoY Change -6.9% 161.84%
Interest Expense -$11.28M -$9.021M
YoY Change 85.41% 111.56%
% of Operating Profit -31.13% -23.87%
Other Income/Expense, Net
YoY Change
Pretax Income $23.64M $28.78M
YoY Change -27.99% 182.88%
Income Tax $5.778M $6.229M
% Of Pretax Income 24.44% 21.65%
Net Earnings $17.77M $22.38M
YoY Change -30.14% 113.23%
Net Earnings / Revenue 3.45% 4.25%
Basic Earnings Per Share $0.55 $0.66
Diluted Earnings Per Share $0.54 $0.65
COMMON SHARES
Basic Shares Outstanding 32.66M shares 34.68M shares
Diluted Shares Outstanding 32.65M shares 34.32M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $43.77M $46.71M
YoY Change -16.02% -42.1%
Cash & Equivalents $43.77M $46.71M
Short-Term Investments
Other Short-Term Assets $59.51M $49.92M
YoY Change 19.64% -24.06%
Inventory $37.52M $37.11M
Prepaid Expenses
Receivables $94.26M $100.0M
Other Receivables $6.947M $13.16M
Total Short-Term Assets $242.0M $246.9M
YoY Change 0.92% -13.75%
LONG-TERM ASSETS
Property, Plant & Equipment $470.4M $253.1M
YoY Change 108.7% 17.06%
Goodwill $76.62M $70.79M
YoY Change 8.33% -1.12%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $68.85M $74.24M
YoY Change -10.18% -12.05%
Total Long-Term Assets $631.6M $618.0M
YoY Change 5.89% 3.1%
TOTAL ASSETS
Total Short-Term Assets $242.0M $246.9M
Total Long-Term Assets $631.6M $618.0M
Total Assets $873.6M $864.9M
YoY Change 4.47% -2.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $55.35M $68.62M
YoY Change 35.51% 93.66%
Accrued Expenses $189.0M $159.9M
YoY Change 12.7% -9.71%
Deferred Revenue $19.59M $20.51M
YoY Change -1.7% 4.37%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $24.72M $8.200M
YoY Change 373.18% 58.0%
Total Short-Term Liabilities $296.8M $272.9M
YoY Change 18.49% -2.05%
LONG-TERM LIABILITIES
Long-Term Debt $795.3M $797.4M
YoY Change 48.25% 50.99%
Other Long-Term Liabilities $246.0M $67.18M
YoY Change 209.37% -24.69%
Total Long-Term Liabilities $1.041B $864.5M
YoY Change 69.05% 40.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $296.8M $272.9M
Total Long-Term Liabilities $1.041B $864.5M
Total Liabilities $1.355B $1.339B
YoY Change 26.74% 22.98%
SHAREHOLDERS EQUITY
Retained Earnings $207.5M $203.6M
YoY Change 6.98% 12.39%
Common Stock $492.0K $492.0K
YoY Change 0.2% 0.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$481.0M -$491.2M
YoY Change
Total Liabilities & Shareholders Equity $873.6M $864.9M
YoY Change 4.47% -2.34%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $17.77M $22.38M
YoY Change -30.14% 113.23%
Depreciation, Depletion And Amortization $15.69M $14.72M
YoY Change 23.2% 23.29%
Cash From Operating Activities $52.95M $40.79M
YoY Change 162.23% 60.62%
INVESTING ACTIVITIES
Capital Expenditures $16.35M $18.41M
YoY Change -179.71% 79.91%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities -$1.103M -$42.00K
YoY Change -106.77% 425.0%
Cash From Investing Activities -$17.45M -$18.28M
YoY Change 314.73% 119.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -38.41M -$23.21M
YoY Change -12.49% 242.01%
NET CHANGE
Cash From Operating Activities 52.95M $40.79M
Cash From Investing Activities -17.45M -$18.28M
Cash From Financing Activities -38.41M -$23.21M
Net Change In Cash -2.913M -$665.0K
YoY Change -89.56% -106.61%
FREE CASH FLOW
Cash From Operating Activities $52.95M $40.79M
Capital Expenditures $16.35M $18.41M
Free Cash Flow $36.60M $22.38M
YoY Change -10.08% 47.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity File Number
EntityFileNumber
0-21660
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
8400000 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000901491
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-26
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
PAPA JOHN’S INTERNATIONAL, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1203323
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2002 Papa John’s Boulevard
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Louisville
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
KY
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
40299-2367
CY2023Q1 dei City Area Code
CityAreaCode
502
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
261-7272
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
PZZA
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32656059 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46708000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47373000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
99997000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
102533000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
7207000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
6848000 usd
CY2023Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
5957000 usd
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
8780000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
37112000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
41382000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
49917000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
44123000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
246898000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
251039000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
253144000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
249793000 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
27847000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
24941000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
170148000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
172425000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent
21242000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent
21248000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
70788000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
70616000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
553000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1920000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
74241000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72245000 usd
CY2023Q1 us-gaap Assets
Assets
864861000 usd
CY2022Q4 us-gaap Assets
Assets
864227000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
68622000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
62316000 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
8180000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
8766000 usd
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
134988000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
142535000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
20508000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
21272000 usd
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
7473000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
6850000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24959000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
23418000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
8200000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
272930000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
265157000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
21733000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
23204000 usd
CY2023Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
21392000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
19022000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
157211000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
160905000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
797362000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
597069000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1112000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
67183000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
68317000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1338923000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1133674000 usd
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1263000 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1217000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49207000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49138000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
492000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
491000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
443686000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
449829000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8766000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10135000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
203569000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
195856000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
16851000 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
14402000 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1130136000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
922434000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-491155000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-286393000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
15830000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
15729000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-475325000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-270664000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
864861000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
864227000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
527049000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
542692000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51944000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
65937000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14721000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11940000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
489253000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
517097000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
11160000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
37796000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
14435000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9021000 usd
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4264000 usd
CY2023Q1 pzza Income Loss From Continuing Operations Before Income Taxes Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesNoncontrollingInterest
28775000 usd
CY2022Q1 pzza Income Loss From Continuing Operations Before Income Taxes Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesNoncontrollingInterest
10171000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6229000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1256000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22546000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
11427000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
170000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
933000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22376000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10494000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22376000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10494000 usd
CY2023Q1 pzza Participating Securities Dividends And Accretion Income Statement Impact
ParticipatingSecuritiesDividendsAndAccretionIncomeStatementImpact
0 usd
CY2022Q1 pzza Participating Securities Dividends And Accretion Income Statement Impact
ParticipatingSecuritiesDividendsAndAccretionIncomeStatementImpact
60000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22376000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10434000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34155000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35927000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34324000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36236000 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.42
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.35
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22546000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
11427000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
1442000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-861000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
336000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
1712000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
1778000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
851000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
332000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-198000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
77000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
394000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
409000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
196000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1369000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
655000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
23915000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
12082000 usd
CY2023Q1 pzza Net Income Loss Attributable To Redeemable Noncontrolling Interest Net Of Tax
NetIncomeLossAttributableToRedeemableNoncontrollingInterestNetOfTax
46000 usd
CY2022Q1 pzza Net Income Loss Attributable To Redeemable Noncontrolling Interest Net Of Tax
NetIncomeLossAttributableToRedeemableNoncontrollingInterestNetOfTax
510000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
124000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
423000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23745000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11149000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-270664000 usd
CY2023Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
22500000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1369000 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
14663000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
614000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
212444000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3898000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5999000 usd
CY2023Q1 pzza Minority Interest Decrease From Distributions To Noncontrolling Interest Holders Including Nonredeemable Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersIncludingNonredeemableNoncontrollingInterestHolders
23000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-87000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-475325000 usd
CY2023Q1 pzza Transaction Costs On Share Repurchases
TransactionCostsOnShareRepurchases
2804000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-172458000 usd
CY2022Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
10917000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
655000 usd
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
12480000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
741000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
32709000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4176000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
7461000 usd
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-175000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-208444000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22546000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
11427000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
513000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
15167000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14721000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11940000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
11160000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2031000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1817000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3898000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4176000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-496000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2135000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2182000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2503000 usd
CY2023Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-2822000 usd
CY2022Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1151000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4330000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4731000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4351000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-77000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-71000 usd
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
654000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-310000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7359000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-512000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
8013000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-5413000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-29469000 usd
CY2023Q1 pzza Increase Decrease In Contract Liabilities
IncreaseDecreaseInContractLiabilities
-2236000 usd
CY2022Q1 pzza Increase Decrease In Contract Liabilities
IncreaseDecreaseInContractLiabilities
-1465000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40788000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25394000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18410000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10233000 usd
CY2023Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
976000 usd
CY2022Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
272000 usd
CY2023Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1069000 usd
CY2022Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
3432000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1250000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-42000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-8000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18275000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8315000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
208200000 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
47000000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
614000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
741000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
209640000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
32709000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
14603000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12608000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5999000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7461000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
23000 usd
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
685000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1761000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1065000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23212000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6787000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-233000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-665000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10059000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47373000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70610000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46708000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80669000 usd
CY2023Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP” or “U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete annual financial statements. In the opinion of management, all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation have been included. Operating results for the three months ended March 26, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. For further information, refer to the consolidated financial statements and footnotes thereto included in the Annual Report on Form 10-K for Papa John’s International, Inc. (referred to as the “Company,” “Papa John’s,” “Papa Johns” or in the first-person notations of “we,” “us” and “our”) for the year ended December 25, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In discussions of our business, “Domestic” is defined as within the contiguous United States, “North America” includes Canada, and “International” includes the rest of the world other than North America.</span></div>
CY2023Q1 pzza Percentage Of Business Units Franchised
PercentageOfBusinessUnitsFranchised
0.85
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
Use of EstimatesThe preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Significant items that are subject to such estimates and assumptions include the allowance for credit losses on accounts and notes receivable, intangible assets, contract assets and contract liabilities including the customer loyalty program obligation, right-of-use assets and lease liabilities, unredeemed gift card liabilities, insurance reserves and tax reserves. Although management bases its estimates on historical experience and assumptions that are believed to be reasonable under the circumstances, actual results could significantly differ from these estimates.
CY2022Q1 pzza Number Of Joint Ventures Divested
NumberOfJointVenturesDivested
1 entity
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
2900000 usd
CY2022Q1 us-gaap Sublease Income
SubleaseIncome
3000000 usd
CY2023Q1 pzza Contingent Liability Number Of Leases
ContingentLiabilityNumberOfLeases
52 lease
CY2023Q1 pzza Contingent Liability Assumed In Sale Of Business
ContingentLiabilityAssumedInSaleOfBusiness
8700000 usd
CY2023Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
309000 usd
CY2022Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
262000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1743000 usd
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1241000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
9178000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
9612000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
4764000 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
569000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4721000 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
20801000 usd
CY2023Q1 pzza Proceeds From Subleases
ProceedsFromSubleases
2532000 usd
CY2022Q1 pzza Proceeds From Subleases
ProceedsFromSubleases
3092000 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
9300000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
42241000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
44476000 usd
CY2023Q1 pzza Contract With Customer Liability Increase Decrease
ContractWithCustomerLiabilityIncreaseDecrease
-2235000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
7000000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6200000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
900000 usd
CY2022Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
800000 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32400000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34700000 shares
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2523000 shares
CY2023Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
83.10
CY2023Q1 pzza Treasury Stock Value Acquired Cost Method Excluding Transaction Costs
TreasuryStockValueAcquiredCostMethodExcludingTransactionCosts
209640000 usd
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
90160000 usd
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
301000 shares
CY2022Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
108.76
CY2022Q1 pzza Treasury Stock Value Acquired Cost Method Excluding Transaction Costs
TreasuryStockValueAcquiredCostMethodExcludingTransactionCosts
32709000 usd
CY2022Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
392091000 usd
CY2023Q1 pzza Transaction Costs On Share Repurchases
TransactionCostsOnShareRepurchases
2800000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
14600000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.42
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
309000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22376000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10494000 usd
CY2023Q1 pzza Participating Securities Dividends And Accretion Income Statement Impact
ParticipatingSecuritiesDividendsAndAccretionIncomeStatementImpact
0 usd
CY2022Q1 pzza Participating Securities Dividends And Accretion Income Statement Impact
ParticipatingSecuritiesDividendsAndAccretionIncomeStatementImpact
60000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22376000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10434000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34155000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35927000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
22376000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
10434000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34155000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35927000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
169000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34324000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36236000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21000 shares
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
813133000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
605000000 usd
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7571000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7931000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
8200000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
797362000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
597069000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9021000 usd
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4264000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
10900000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
10100000 usd
CY2022Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2800000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
527049000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
542692000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
37796000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
14435000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
551975000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
253144000 usd
CY2022Q1 pzza Refranchising Gains Losses Net
RefranchisingGainsLossesNet
-8400000 usd
CY2023Q1 us-gaap Severance Costs1
SeveranceCosts1
1400000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
527049000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
542692000 usd

Files In Submission

Name View Source Status
0001628280-23-015436-index-headers.html Edgar Link pending
0001628280-23-015436-index.html Edgar Link pending
0001628280-23-015436.txt Edgar Link pending
0001628280-23-015436-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pzza-20230326.htm Edgar Link pending
pzza-20230326.xsd Edgar Link pending
pzza-20230326xexx311.htm Edgar Link pending
pzza-20230326xexx312.htm Edgar Link pending
pzza-20230326xexx321.htm Edgar Link pending
pzza-20230326xexx322.htm Edgar Link pending
pzza-20230326_g1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pzza-20230326_def.xml Edgar Link unprocessable
pzza-20230326_cal.xml Edgar Link unprocessable
pzza-20230326_pre.xml Edgar Link unprocessable
pzza-20230326_lab.xml Edgar Link unprocessable
pzza-20230326_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending